Precise mycobacterial species and subspecies identification using the PEP-TORCH peptidome algorithm
Duran Bao1,2, Sudipa Maity1,2, Lingpeng Zhan1,2
1Center for Cellular and Molecular Diagnostics, Tulane University School of Medicine, New Orleans, LA, 70112, USA.
EMBO Molecular Medicine
|March 4, 2025
Summary
A new peptidome-based method, PEP-TORCH, accurately identifies mycobacterial species and subspecies from MGIT cultures, significantly speeding up diagnosis and improving treatment strategies for these global health threats.
Area of Science:
- Clinical microbiology
- Proteomics
- Infectious diseases
Background:
- Mycobacterial infections are a major global health issue.
- Current diagnostic methods are often slow and inaccurate, delaying effective treatment.
- Precise identification of mycobacterial species and subspecies is crucial for targeted therapy.
Purpose of the Study:
- To develop a novel, rapid, and accurate peptidome-based method for mycobacterial identification.
- To utilize mass spectrometry and a custom algorithm (PEP-TORCH) for enhanced diagnostic capabilities.
- To streamline the identification process compared to conventional methods.
Main Methods:
- Development of the PEPtide Taxonomy/ORganism CHecking (PEP-TORCH) algorithm.
- Analysis of tryptic peptides from Mycobacterial Growth Indicator Tube (MGIT) cultures using mass spectrometry.
- Validation of a targeted proteomics approach using PEP-TORCH-selected biomarkers.
Main Results:
- PEP-TORCH achieved 100% accuracy in identifying mycobacterial species, subspecies, and co-infections in 81 individuals.
- The method eliminated the need for the traditional sub-solid culture procedure.
- Simultaneous species and subspecies identification significantly expedited pathogen detection.
Conclusions:
- The PEP-TORCH method offers a faster and more accurate approach to diagnosing mycobacterial infections.
- Validated targeted proteomics biomarkers can be used in clinically friendly settings.
- This comprehensive identification strategy promises to optimize clinical treatment strategies.


